The Department of Veterans Affairs, Veterans Health Administration (VA-VHA) has awarded an Indefinite Delivery Contract (IDC) worth up to $3,118,396.46 to Roche Diagnostics Corporation to provide immunohistochemistry cost per test services. This single-award IDC has a period of performance through September 30, 2027.
Under this contract, Roche Diagnostics has been issued a series of firm-fixed price delivery orders to perform immunohistochemistry testing services in support of VA healthcare facilities in the Tampa, Florida region. The total value of the delivery orders awarded to date is approximately $4.3 million. This contract allows the VA to readily acquire immunohistochemistry diagnostic testing capabilities from an established vendor to support pathology services for veterans and other eligible patients treated at VA medical centers. As a leading provider of in vitro diagnostics and laboratory equipment, Roche Diagnostics is well-positioned to fulfill the VA's need for reliable, high-quality immunohistochemistry testing on a regional basis.
Generated 10/2/24, 9:07 AM